CASE DESCRIPTION: A 7-year-old Quarter Horse gelding was hospitalized in Ocala, Fla, because of lethargy, fever, anorexia, and swelling of distal aspects of the limbs. A tentative diagnosis of equine piroplasmosis (EP) was made on the basis of examination of a blood smear. The case was reported to the Florida State Veterinarian, and infection with Babesia equi was confirmed. The subsequent investigation included quarantine and testing of potentially exposed horses for B equi and Babesia caballi infections, tick surveillance, and owner-agent interviews. CLINICAL FINDINGS: 210 horses on 25 premises were tested for infection with EP pathogens. Twenty B equi-infected horses on 7 premises were identified; no horses tested positive for B caballi. Seven horses, including the index case, had clinical findings consistent with EP Dermacentor variabilis was considered the only potential tick vector for B equi collected, and all D variabilis specimens tested negative for Babesia organisms via PCR assay. Results of the epidemiological investigation suggested that B equi was spread by use of shared needles and possibly blood transfusions. All horses that tested positive were involved in nonsanctioned Quarter Horse racing, and management practices were thought to pose substantial risk of transmission of blood-borne pathogens. TREATMENT AND OUTCOME: Final outcome of B equi-infected horses was euthanasia, death from undetermined causes, or shipment to a US federal research facility. CLINICAL RELEVANCE: This investigation highlights the importance of collaboration between private veterinary practitioners, state veterinary diagnostic laboratories, and regulatory officials in the recognition, containment, and eradication of foreign animal disease.
CASE DESCRIPTION: A 7-year-old Quarter Horse gelding was hospitalized in Ocala, Fla, because of lethargy, fever, anorexia, and swelling of distal aspects of the limbs. A tentative diagnosis of equine piroplasmosis (EP) was made on the basis of examination of a blood smear. The case was reported to the Florida State Veterinarian, and infection with Babesia equi was confirmed. The subsequent investigation included quarantine and testing of potentially exposed horses for B equi and Babesia caballi infections, tick surveillance, and owner-agent interviews. CLINICAL FINDINGS: 210 horses on 25 premises were tested for infection with EP pathogens. Twenty B equi-infected horses on 7 premises were identified; no horses tested positive for B caballi. Seven horses, including the index case, had clinical findings consistent with EP Dermacentor variabilis was considered the only potential tick vector for B equi collected, and all D variabilis specimens tested negative for Babesia organisms via PCR assay. Results of the epidemiological investigation suggested that B equi was spread by use of shared needles and possibly blood transfusions. All horses that tested positive were involved in nonsanctioned Quarter Horse racing, and management practices were thought to pose substantial risk of transmission of blood-borne pathogens. TREATMENT AND OUTCOME: Final outcome of B equi-infected horses was euthanasia, death from undetermined causes, or shipment to a US federal research facility. CLINICAL RELEVANCE: This investigation highlights the importance of collaboration between private veterinary practitioners, state veterinary diagnostic laboratories, and regulatory officials in the recognition, containment, and eradication of foreign animal disease.
Authors: Wesley C Van Voorhis; J Stone Doggett; Marilyn Parsons; Matthew A Hulverson; Ryan Choi; Samuel L M Arnold; Michael W Riggs; Andrew Hemphill; Daniel K Howe; Robert H Mealey; Audrey O T Lau; Ethan A Merritt; Dustin J Maly; Erkang Fan; Kayode K Ojo Journal: Exp Parasitol Date: 2017-01-05 Impact factor: 2.011
Authors: Fernanda Gimenez; Siddra A Hines; Ryan Evanoff; Kayode K Ojo; Wesley C Van Voorhis; Dustin J Maly; Rama S R Vidadala; Robert H Mealey Journal: Vet Parasitol Date: 2018-01-01 Impact factor: 2.738
Authors: Adrian Alberto Díaz-Sánchez; Marcus Sandes Pires; Carlos Yrurzun Estrada; Ernesto Vega Cañizares; Sergio Luis Del Castillo Domínguez; Alejandro Cabezas-Cruz; Evelyn Lobo Rivero; Adivaldo Henrique da Fonseca; Carlos Luiz Massard; Belkis Corona-González Journal: Parasitol Res Date: 2018-07-23 Impact factor: 2.289
Authors: Peter O Awinda; Robert H Mealey; Laura B A Williams; Patricia A Conrad; Andrea E Packham; Kathryn E Reif; Juanita F Grause; Angela M Pelzel-McCluskey; Chungwon Chung; Reginaldo G Bastos; Lowell S Kappmeyer; Daniel K Howe; SallyAnne L Ness; Donald P Knowles; Massaro W Ueti Journal: Clin Vaccine Immunol Date: 2013-09-18
Authors: Idoko S Idoko; Richard E Edeh; Andrew M Adamu; Salamatu Machunga-Mambula; Oluyinka O Okubanjo; Emmanuel O Balogun; Sani Adamu; Wendell Johnson; Lowell Kappmeyer; Michelle Mousel; Massaro W Ueti Journal: Pathogens Date: 2021-04-23
Authors: Massaro W Ueti; Robert H Mealey; Lowell S Kappmeyer; Stephen N White; Nancy Kumpula-McWhirter; Angela M Pelzel; Juanita F Grause; Thomas O Bunn; Andy Schwartz; Josie L Traub-Dargatz; Amy Hendrickson; Benjamin Espy; Alan J Guthrie; W Kent Fowler; Donald P Knowles Journal: PLoS One Date: 2012-09-06 Impact factor: 3.240
Authors: Carina M Hall; Joseph D Busch; Glen A Scoles; Kristina A Palma-Cagle; Massaro W Ueti; Lowell S Kappmeyer; David M Wagner Journal: Parasit Vectors Date: 2013-02-11 Impact factor: 3.876
Authors: Lowell S Kappmeyer; Mathangi Thiagarajan; David R Herndon; Joshua D Ramsay; Elisabet Caler; Appolinaire Djikeng; Joseph J Gillespie; Audrey Ot Lau; Eric H Roalson; Joana C Silva; Marta G Silva; Carlos E Suarez; Massaro W Ueti; Vishvanath M Nene; Robert H Mealey; Donald P Knowles; Kelly A Brayton Journal: BMC Genomics Date: 2012-11-09 Impact factor: 3.969